Skip to main content
DFNS
NASDAQ Trade & Services

T3 Defense Subsidiary Sells AI Defense Tech Unit for $1.25M Note, BiomX Shares, and Earnout

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$0.477
Mkt Cap
$13.9M
52W Low
$0.421
52W High
$26.21
Market data snapshot near publication time

summarizeSummary

T3 Defense Inc., through its subsidiary Water IO Ltd., completed the sale of its AI defense technology unit, Zorronet, to BiomX Inc. for $1.25 million in a promissory note, 1.3 million BiomX shares, and a performance-based earnout.


check_boxKey Events

  • Subsidiary Sale Completed

    Water IO Ltd., a 67%-owned subsidiary of T3 Defense, sold 100% of its AI defense technology unit, Zorronet, to BiomX Inc. on April 10, 2026.

  • Consideration Received

    The sale generated a $1.25 million non-convertible promissory note and 1,300,000 shares of BiomX common stock. Water IO now holds approximately 16.57% of BiomX's outstanding common stock.

  • Performance-Based Earnout

    BiomX also assumed obligations for a performance-based earnout to Zorronet's founders, payable by March 31, 2027, tied to 2026 revenue or EBITDA.

  • Strategic Restructuring

    This transaction follows a recent 10-K filing disclosing a going concern warning, suggesting a strategic move to bolster the company's financial position and address liquidity concerns.


auto_awesomeAnalysis

This disposition of a key subsidiary, Zorronet, provides T3 Defense with immediate capital through a $1.25 million promissory note and a significant equity stake in BiomX Inc. The transaction, which also includes a performance-based earnout, could substantially improve T3 Defense's financial position, especially in light of the "going concern" warning disclosed in its recent 10-K filing. This strategic move suggests the company is actively restructuring its assets to address liquidity concerns and extend its operational runway. Investors should monitor how these new assets are utilized and the impact on the company's overall financial health.

At the time of this filing, DFNS was trading at $0.48 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $13.9M. The 52-week trading range was $0.42 to $26.21. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DFNS - Latest Insights

DFNS
Apr 28, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
9
DFNS
Apr 28, 2026, 8:15 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
DFNS
Apr 28, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
DFNS
Apr 16, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
DFNS
Apr 15, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
DFNS
Apr 15, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
DFNS
Apr 14, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
DFNS
Apr 14, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
DFNS
Apr 10, 2026, 3:40 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
DFNS
Apr 10, 2026, 12:50 PM EDT
Filing Type: 8-K
Importance Score:
8